| Neoadjuvant immunoradiotherapy in patients with locally advanced oral cavity squamous cell carcinoma: a retrospective study. Shen 2022 · Shen Peng, Qiao Bo, et al. · Investigational new drugs PMID:35972629 | 2022 | 2 | none stated | not extracted yet |
| Neoadjuvant camrelizumab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, open-label study. Wang 2024 · Wang Jianping, Zhang Jian, et al. · Advances in clinical and experimental medicine : official organ Wroclaw Medical University PMID:37676100 | 2024 | 1 | none stated | not extracted yet |
| Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study. Park 2024 · Park Sehhoon, Lee Yurimi, et al. · Cancer research and treatment PMID:37846467 | 2024 | 1 | none stated | not extracted yet |
| Complete responses after neoadjuvant toripalimab and chemoradiotherapy for oesophageal squamous cell carcinoma: in situ and ex vivo 3.0 T MRI… Zhao 2024 · Zhao Lijun, Zhu Xiangzhi, et al. · The British journal of surgery PMID:37931155 | 2024 | 1 | none stated | not extracted yet |
| Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial. Li 2024 · Li Kezhen, Chen Jing, et al. · The Lancet. Oncology PMID:38048802 | 2024 | 1 | none stated | not extracted yet |
| Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study… Yang 2024 · Yang Yingnan, Zhang Jinfeng, et al. · International journal of surgery (London, England) PMID:38051925 | 2024 | 1 | none stated | not extracted yet |
| Study on the efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy regimen for III-IVA esophageal squamous cell carcinoma… Li 2024 · Li Chunyang, Yu Pengyi, et al. · Journal of cardiothoracic surgery PMID:38273405 | 2024 | 1 | none stated | not extracted yet |
| Retrospective assessment of neoadjuvant camrelizumab combined with induction chemotherapy: efficacy in laryngeal preservation for advanced… Peng 2024 · Peng Jin, Luo Guangfeng, et al. · Cancer immunology, immunotherapy : CII PMID:38358522 | 2024 | 1 | none stated | not extracted yet |
| Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer. Xu 2024 · Xu Xin, Sun Zhiyong, et al. · Journal for immunotherapy of cancer PMID:38458635 | 2024 | 1 | none stated | not extracted yet |
| Neoadjuvant PD-1 Plus Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Qian 2024 · Qian Ting, Liu Delin, et al. · Technology in cancer research & treatment PMID:38497137 | 2024 | 1 | none stated | not extracted yet |
| Neoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma. Kim 2024 · Kim Emily Y, Ruiz Emily S, et al. · JAMA otolaryngology-- head & neck surgery PMID:38546619 | 2024 | 1 | none stated | not extracted yet |
| Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma. Lv 2024 · Lv Huilai, Zhang Fan, et al. · Journal of cancer research and clinical oncology PMID:38760614 | 2024 | 1 | none stated | not extracted yet |
| Efficacy, safety, and survival of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: A real-world… Guo 2024 · Guo Yiyu, Xu Xinyu, et al. · International immunopharmacology PMID:38941666 | 2024 | 1 | none stated | not extracted yet |
| Real-world retrospective study of anti-PD-1 antibody in combination with chemotherapy as a neoadjuvant treatment strategy for locally advanced… Liu 2024 · Liu Can, Yu Yi, et al. · Journal of thoracic disease PMID:39144348 | 2024 | 1 | none stated | not extracted yet |
| Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label,… Chen 2023 · Chen Xiaofeng, Xu Xiang, et al. · Journal for immunotherapy of cancer PMID:36759013 | 2023 | 1 | none stated | not extracted yet |
| Neoadjuvant pembrolizumab and chemotherapy in resectable clinical stage III non-small-cell lung cancer: a retrospective cohort study. Zhao 2023 · Zhao Guangyin, Zhang Hongyu, et al. · Translational lung cancer research PMID:36762056 | 2023 | 1 | none stated | not extracted yet |
| Pathological response and prognostic factors of neoadjuvant PD-1 blockade combined with chemotherapy in resectable oesophageal squamous cell… Wang 2023 · Wang Honglei, Jiang Zeying, et al. · European journal of cancer (Oxford, England : 1990) PMID:37045666 | 2023 | 1 | none stated | not extracted yet |
| Neoadjuvant camrelizumab plus chemotherapy in locally advanced oesophageal squamous cell carcinoma: a retrospective cohort study. Zhou 2023 · Zhou Rui-Qin, Luo Jun, et al. · BMC surgery PMID:37161374 | 2023 | 1 | none stated | not extracted yet |
| Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial). Huang 2023 · Huang Yingying, Sun Jingjing, et al. · International journal of surgery (London, England) PMID:37288582 | 2023 | 1 | none stated | not extracted yet |
| A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma. Patel 2023 · Patel Shetal A, Gibson Michael K, et al. · Cancer PMID:37395170 | 2023 | 1 | none stated | not extracted yet |
| Neoadjuvant adebrelimab in locally advanced resectable esophageal squamous cell carcinoma: a phase 1b trial. Yin 2023 · Yin Jun, Yuan Jingnan, et al. · Nature medicine PMID:37488287 | 2023 | 1 | none stated | not extracted yet |
| Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous… Wang 2023 · Wang Kai, Gui Lin, et al. · Frontiers in immunology PMID:37583698 | 2023 | 1 | none stated | not extracted yet |
| PD-1 Inhibitors combined with paclitaxel (Albumin-bound) and cisplatin for larynx preservation in locally advanced laryngeal and hypopharyngeal… Fang 2023 · Fang Qi, Xu Pengfei, et al. · Cancer immunology, immunotherapy : CII PMID:37804437 | 2023 | 1 | none stated | not extracted yet |
| Evaluation of neoadjuvant chemotherapy combined with PD-1 inhibitors in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma: a… Xu 2023 · Xu Pengfei, Fang Qi, et al. · Cancer immunology, immunotherapy : CII PMID:37837458 | 2023 | 1 | none stated | not extracted yet |
| Evaluation of the efficacy and surgical-related safety of neoadjuvant immunochemotherapy in advanced resectable none small cell lung cancer (NSCLC). Wang 2023 · Wang Qin, Qi Chen, et al. · Frontiers in oncology PMID:38205138 | 2023 | 1 | none stated | not extracted yet |
| Neoadjuvant sintilimab plus chemotherapy for locally advanced resectable esophageal squamous cell carcinoma: a prospective, single-arm, phase II… Chen 2023 · Chen Yuzhen, Ren Meiyu, et al. · Journal of thoracic disease PMID:38249875 | 2023 | 1 | none stated | not extracted yet |
| Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a… Hong 2022 · Hong Zhi-Nuan, Zhang Zhenyang, et al. · Esophagus : official journal of the Japan Esophageal Society PMID:34988773 | 2022 | 1 | none stated | not extracted yet |
| Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma. He 2022 · He Wenwu, Leng Xuefeng, et al. · The oncologist PMID:35305102 | 2022 | 1 | none stated | not extracted yet |
| Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell… Liu 2022 · Liu Jun, Yang Yang, et al. · Journal for immunotherapy of cancer PMID:35338088 | 2022 | 1 | none stated | not extracted yet |
| Toripalimab combined with docetaxel and cisplatin neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a single-center,… Gao 2022 · Gao Lei, Lu Jieming, et al. · Journal of gastrointestinal oncology PMID:35557591 | 2022 | 1 | none stated | not extracted yet |
| Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma. Lv 2022 · Lv Huilai, Tian Yang, et al. · Frontiers in oncology PMID:35574384 | 2022 | 1 | none stated | not extracted yet |
| Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in… Yang 2022 · Yang Yang, Tan Lijie, et al. · Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus PMID:35649396 | 2022 | 1 | none stated | not extracted yet |
| Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE). Duan 2022 · Duan Hongtao, Shao Changjian, et al. · Frontiers in immunology PMID:35720388 | 2022 | 1 | none stated | not extracted yet |
| Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial. Zhang 2022 · Zhang Zhanjie, Wu Bian, et al. · Clinical cancer research : an official journal of the American Association for Cancer Research PMID:35766967 | 2022 | 1 | none stated | not extracted yet |
| The Safety and Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: A… Yin 2022 · Yin Guo-Qiang, Li Zu-Lei, et al. · Cancer management and research PMID:35795828 | 2022 | 1 | none stated | not extracted yet |
| Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma-A Real-World… Huang 2022 · Huang Shujie, Wu Hansheng, et al. · Frontiers in immunology PMID:35911702 | 2022 | 1 | none stated | not extracted yet |
| Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An… Huang 2022 · Huang Xiaotao, Liu Qiaodan, et al. · Journal of experimental & clinical cancer research : CR PMID:36224603 | 2022 | 1 | none stated | not extracted yet |
| Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trial. Zhang 2022 · Zhang Zhi, Ye Jinjun, et al. · Frontiers in immunology PMID:36311804 | 2022 | 1 | none stated | not extracted yet |
| The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma. Lv 2023 · Lv Huilai, Huang Chao, et al. · Frontiers in immunology PMID:36741358 | 2022 | 1 | none stated | not extracted yet |
| The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma. Shen 2021 · Shen Dijian, Chen Qixun, et al. · Journal of gastrointestinal oncology PMID:33708420 | 2021 | 1 | none stated | not extracted yet |
| Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label,… Duan 2021 · Duan Hongtao, Wang Tianhu, et al. · Translational lung cancer research PMID:33718040 | 2021 | 1 | none stated | not extracted yet |
| Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Ferrarotto 2021 · Ferrarotto Renata, Amit Moran, et al. · Clinical cancer research : an official journal of the American Association for Cancer Research PMID:34187851 | 2021 | 1 | none stated | not extracted yet |
| Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma. Wu 2021 · Wu Zhigang, Zheng Qiang, et al. · Journal of thoracic disease PMID:34277047 | 2021 | 1 | none stated | not extracted yet |
| Neoadjuvant camrelizumab plus chemotherapy in treating locally advanced esophageal squamous cell carcinoma patients: a pilot study. Yang 2021 · Yang Peng, Zhou Xiao, et al. · World journal of surgical oncology PMID:34809658 | 2021 | 1 | none stated | not extracted yet |